SlidesetHIVInternational Workshop on HIV & Women 202090: 90: 90: Which Women Are Being Left Behind? - Patricia Vasquez, MDView Slideset
SlidesetHIVInternational Workshop on HIV & Women 202090-90-90: Which Women Are Being Left Behind? - Tendani Gaolathe, MDView Slideset
SlidesetHIVInternational Workshop on HIV & Women 202090: 90: 90: Which Women Are Being Left Behind? - Mariana Mardarescu, MD, PhDView Slideset
SlidesetHIVInternational Workshop on HIV & Women 2020Which Women are Left Behind in North America? - Sally Hodder, MDView Slideset
SlidesetHIVInternational Workshop on HIV & Women 2020Better, earlier pregnancy and lactation data for new HIV drugs: how do we get there - Shahin Lockman, MD, MScView Slideset
SlidesetHIVInternational Workshop on HIV & Women 2020Not recommended, but done: Breastfeeding with HIV in Germany - Lila Haberl, MDView Slideset
FMFungai MurauMCIM, MASlidesetHIVInternational Workshop on HIV & Women 2020U = U Applies to Women! - Fungai Murau, MAView Slideset
SlidesetHIVInternational Workshop on HIV & Women 2020U = U Applies to Women! 2- Lena Serghides, PhDView Slideset
LSLena SerghidesPhDSlidesetHIVInternational Workshop on HIV & Women 2020U = U Applies to Women! - Lena Serghides, PhDView Slideset
SlidesetHIVInternational Workshop on HIV & Women 2020U = U Applies to Women! - Natella Rakhmanina, MD, PhD, FAAP, AAHIVView Slideset
NRNatella RakhmaninaMD, PhD, FAAP, FCP, AAHIVSSlidesetHIVInternational Workshop on HIV & Women 2020U=U does apply to women! - Natella Rakhmanina, MD, PhDView Slideset
AbstractHIVInternational Workshop on HIV & Women 2020Outcomes following prenatal exposure to Dolutegravir: the Dolomite - EPPICC Study - Claire Thorne, BA, MSc, PhDView Abstract
